Iloperidone/lithiumPriapism: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2014年 / 1511卷 / 1期
关键词：
D O I：
10.1007/s40278-014-2160-3
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：23 / 23
相关论文
共 50 条
  • [21] Iloperidone: A new drug for the treatment of schizophrenia
    Arif, Sally A.
    Mitchell, Melissa M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (04) : 301 - 308
  • [22] Bridging study of iloperidone in schizophrenic inpatients
    Cutler, NR
    Shipley, JE
    Varaklis, J
    Hourani, J
    Jhee, SS
    Sramek, JJ
    PSYCHOPHARMACOLOGY BULLETIN, 1996, 32 (03) : 428 - 428
  • [23] New atypical antipsychotics for schizophrenia: iloperidone
    Caccia, Silvio
    Pasina, Luca
    Nobili, Alessandro
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2010, 4 : 33 - 48
  • [24] An Evaluation of Iloperidone for Mania in Bipolar I Disorder
    Caskey, Kelen
    Nelson, Leigh Anne
    ANNALS OF PHARMACOTHERAPY, 2025,
  • [25] Iloperidone: a new option for the treatment of schizophrenia
    Cutler, Andrew J.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (12) : 1727 - 1741
  • [26] FDA APPROVES ILOPERIDONE FOR THE TREATMENT OF SCHIZOPHRENIA
    Naccari, Christopher
    CNS SPECTRUMS, 2009, 14 (06) : 286 - 286
  • [27] Syntheses and pharmacokinetics properties of an iloperidone pharmaceutical cocrystal
    Zhang, Ting-Ting
    Wang, Hai-Tao
    Jia, Jiang-Tao
    Cui, Xiao-Qiang
    Li, Qin
    Zhu, Guang-Shan
    INORGANIC CHEMISTRY COMMUNICATIONS, 2014, 39 : 144 - 146
  • [28] Dose proportionality of iloperidone in patients with schizophrenia.
    Vaidyanathan, S
    Barilla, D
    Choudhury, S
    Gumbhir-Shah, K
    Hayes, M
    Prasad, P
    Ma, P
    Sedek, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P68 - P68
  • [29] Iloperidone - A novel atypical antipsychotic for the treatment of schizophrenia
    Ehret, Megan J.
    Sopko, Michael A., Jr.
    Levine, Alexander
    FORMULARY, 2008, 43 (06) : 190 - +
  • [30] Iloperidone (Fanapt) - A New Indication for Bipolar Disorder
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2024, 66 (1707):
12345